Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy
- PMID: 17005529
- DOI: 10.1093/ndt/gfl512
Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy
Abstract
Background: The MTHFR C677T single nucleotide polymorphism TT genotype is associated with increased levels of plasma homocysteine and possibly an effect on cardiovascular mortality. We evaluated the effect of C677T genotype on mortality in a large end-stage renal disease (ESRD) cohort.
Methods: C677T genotype was determined in 439 Caucasians with end-stage diabetic nephropathy (DNP) (cases) recruited from 30 dialysis centres in Southern Germany. A total of 482 type 2 diabetes patients without DNP (no microalbuminuria) at inclusion served as a genotype control collective. Patients were prospectively followed for 4 years. Primary endpoint was all-cause mortality.
Results: In contrast to controls, the genotype distribution in cases was not in Hardy-Weinberg equilibrium (HWE, P = 0.003), due to a less than expected number of patients with the TT genotype. The requirements of HWE were met in cases with < 2 years dialysis therapy prior to study inclusion (n = 219). TT genotype was associated with a decreased body mass index (P = 0.002) and long diabetes duration in dialysis patients (P = 0.03). However, TT genotype was not associated with an increased risk of all-cause or cardiac mortality in the total dialysis collective or the subgroup. Also, we observed no association of MTHFR genotype with cardiovascular morbidity in cases or controls (P > 0.05), or with an increased rate of progression to novel microalbuminuria.
Conclusion: MTHFR 677TT genotype was significantly underrepresented in patients with ESRD in our study, but was not associated with premature mortality in these patients. We found no evidence for survival bias due to C677T genotype in the ESRD cohort, or bias due to genetically determined accelerated progression to novel microalbuminuria in the controls. However, we cannot exclude that the TT genotype protects from progression from microalbuminuria to more advanced stages of DNP, or that TT genotype is associated with premature mortality before a patient progresses to ESRD.
Similar articles
-
The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus.Med Sci Monit. 2004 Feb;10(2):BR47-51. Med Sci Monit. 2004. PMID: 14737040
-
Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: a prospective study.Am J Kidney Dis. 2009 May;53(5):779-89. doi: 10.1053/j.ajkd.2008.12.023. Epub 2009 Mar 9. Am J Kidney Dis. 2009. PMID: 19272686 Clinical Trial.
-
MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.Diabetes Res Clin Pract. 2007 Jan;75(1):99-106. doi: 10.1016/j.diabres.2006.05.018. Epub 2006 Jul 7. Diabetes Res Clin Pract. 2007. PMID: 16828193
-
Methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism and diabetic nephropathy susceptibility in patients with type 2 diabetes mellitus.Ren Fail. 2015;37(8):1247-59. doi: 10.3109/0886022X.2015.1064743. Epub 2015 Jul 10. Ren Fail. 2015. PMID: 26161693 Review.
-
Relationship between methylenetetrahydrofolate reductase (MTHFR) A1298C gene polymorphism and type 2 diabetic nephropathy risk: a meta-analysis.Ren Fail. 2014 Jul;36(6):974-8. doi: 10.3109/0886022X.2014.900426. Epub 2014 Mar 31. Ren Fail. 2014. PMID: 24678913 Review.
Cited by
-
HLA class II is a factor in cardiovascular morbidity and mortality rates in patients with type 1 diabetes.Diabetologia. 2012 Nov;55(11):2963-9. doi: 10.1007/s00125-012-2670-6. Epub 2012 Aug 17. Diabetologia. 2012. PMID: 22898764
-
Decisive evidence corroborates a null relationship between MTHFR C677T and chronic kidney disease: A case-control study and a meta-analysis.Medicine (Baltimore). 2020 Jul 17;99(29):e21045. doi: 10.1097/MD.0000000000021045. Medicine (Baltimore). 2020. PMID: 32702845 Free PMC article.
-
Folic acid attenuates cognitive dysfunction in streptozotocin-induced diabetic rats.Int J Clin Exp Med. 2014 Nov 15;7(11):4214-9. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25550933 Free PMC article.
-
Prevalence of methylenetetrahydrofolate gene (MTHFR) C677T polymorphism among chronic hemodialysis patients and its association with cardiovascular disease: a cross-sectional analysis.Clin Exp Nephrol. 2009 Oct;13(5):501-507. doi: 10.1007/s10157-009-0194-2. Epub 2009 May 26. Clin Exp Nephrol. 2009. PMID: 19466593
-
Methylenetetrahydrofolate reductase genetic polymorphism and the risk of diabetic nephropathy in type 2 diabetic patients.Medicine (Baltimore). 2020 Aug 28;99(35):e21558. doi: 10.1097/MD.0000000000021558. Medicine (Baltimore). 2020. PMID: 32871871 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous